Development Drugs Life Science Pharma R&D 
Drug Discovery World
APRIL 24, 2024
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has supported the use of artificial intelligence (AI) to deliver benefit for patients, life science companies and society, in response to the EU Artificial Intelligence (AI) Act.
pharmaphorum
JUNE 16, 2021
Due to increasing complexity in R&D, pharma teams are under pressure to drive down costs and speed up time to market whilst improving outcomes, and most recognise that incorporating automation and AI into their workflows will be game-changing. ” Changing team culture. Ensuring a future of Computer-Aided Biology.
Expert insights. Personalized for you.
52 
Let's personalize your content